|
|
Post by kc on Jul 29, 2024 20:38:54 GMT -5
Stocktwits is saying that Fundstrat's Tom Lee is recommending MNKD to his followers. Is anyone a subscriber who could confirm that? The smoke signals are out there or is it just chum in the water? I think we will see very shortly. |
|
|
|
Post by kc on Jul 29, 2024 20:34:46 GMT -5
I hope Martine announces the deal to acquire Mannkind during his call on July 31.
Stock deal valued $33.00 per share MNKD = 10% of current UTHR therapeutic price today.
Seems like a good value to me for shares in both Companies.
I would take an all stock deal from United therapeutics.
|
|
|
|
Post by kc on Jul 26, 2024 16:15:30 GMT -5
Still holding after all these years. You're making this a habit...popping in unannounced 2x a year.  Just leading a very busy life. I wish I could pop up more often, but I never lost faith in the company, the management And hopefully one day will be blessed with some great news. Funny thing is I have so many other investments. And they’ve all done really well, especially in comparison to my return on Mannkind. It taught me a lot about disciplined investing And patience. If I would take what my original investment has been in this company and had put it into Apple, broad com, Nvidia, Google, I would be much further ahead. But I would not have learned as much about a good product and the good investors who have been hanging around waiting for something big to happen. Lessons learned. |
|
|
|
Post by kc on Jul 22, 2024 3:14:45 GMT -5
Still holding after all these years.
|
|
|
|
Post by kc on Apr 3, 2024 13:57:21 GMT -5
Anytime debt is paid off it’s a positive thing. Very happy to see these two debts out of the way. This is huge milestone for MannKind. Just think where the company was 5 years ago and where we are today. Next year we should see Afrezza Peds approval and Clofazimine approval and Nintedanib in Phase 3. Incredible. I see this as a $20-$25 stock following those events. I’ve been searching so long! Reminds me of a Chicago song. youtu.be/08sDz9Fqfnc?si=J2jzkJa93zJmsEF0As my life goes on, I believe Somehow something's changed Something deep inside Ooh, a part of me There's a strange new light in my eyes (there's a strange new light) Things I've never known Changing my life Changing me I've been searching so long To find an answer Now I know my life has meaning, oh yeah Now I see myself as I am Feeling very free Life is everything Ooh, it's meant to be When my tears have come to an end I will understand (yes I will) What I left behind Part of me I've been searching so long To find an answer Now I know my life has meaning Wait a minute Searching (don't you know I'm searching?) For an answer To the question Oh, yeah Who am I? (Yeah yeah, yeah, yeah) (Ooh, yeah, yeah, yeah) Baby (baby) It's true It's only natural (it's only natural, baby) Good things In life Take a long time |
|
|
|
Post by kc on Apr 3, 2024 13:52:38 GMT -5
If the Mann group received shares and sold some/all of them, that would definitely put a temporary downward pressure on the stock Mann Group has come this far. I doubt they are going to sell it out until they get ultimately what they feel. The real value is worth. |
|
|
|
Post by kc on Apr 3, 2024 7:54:39 GMT -5
Looks to be a great move on the part of the company. They keep working to get their house in order..
makes it easier to give the keys to the next owner 😉
|
|
|
|
Post by kc on Aug 9, 2023 11:16:55 GMT -5
It’s going to be interesting watching this over the next quarter. I would bet that if we stay in the $6. per share range or climb up to the $7. range and we blow the doors off in the next quarter. This thing will be $10 before the end of the year.
Even if we stay in the $6. range, the next quarter will blow the doors open.
Hopefully our patience will pay off to all of us who have been around since 2014
|
|
|
|
Post by kc on Aug 7, 2023 16:11:23 GMT -5
Nothing in the chat
|
|
|
|
Post by kc on Aug 7, 2023 15:44:19 GMT -5
“We are excited to report positive income from operations in the second quarter driven by growing patient demand for Tyvaso DPI® and Afrezza as well as manufacturing revenues from Tyvaso DPI,” said Michael Castagna, PharmD, Chief Executive Officer of MannKind Corporation. “In addition, we have optimized our commercial operations supporting Afrezza® and V-Go®, which is expected to get our Endocrine Business Unit to profitability starting in 2024.” I smell $6.00 per share on Tuesday morning |
|
|
|
Post by kc on Aug 2, 2023 19:30:52 GMT -5
Mike selling before UTHR ER for tax purposes was a bone head move unless he don't think sp is not going up. Perhaps not. We don’t know his reason for selling, but I’m sure it had to do with taxation. Also, you don’t know what options he has coming up that he has to fund. Sometimes these things are scheduled and he can’t change it. Because of confidentialities rules, he can’t tell us what is going on, but you would have to think that eventually there’s going to be a deal made with United therapeutics to buy into Mannkind. It will happen SHORTLY! |
|
|
|
Post by kc on Aug 2, 2023 12:17:53 GMT -5
MNKD volume at 30 mins of trade, 564,822 shares AUG 2, 2023 10:00 AM ET MNKD opened at 125,000 shares. $4.47 0.33% -0.015 T Nasdaq -196. Call me crazy. Should’ve bought more when it was cheaper. But then again, I have so many shares that have mold on them. It was time to add another 9000 shares to my portfolio this morning. Oy! This time I don’t think I’m crazy. |
|
|
|
Post by kc on May 24, 2023 19:49:32 GMT -5
Is this a signal to the shareholder community when they start buying stock in this manner? A cool $150,000 into company coffers on the stock purchases made here. Like to see these for a good change of pace. GLTA |
|
|
|
Post by kc on Apr 17, 2023 15:21:39 GMT -5
I was there! I kept thinking it wouldn't be long until the production capacity of that place wouldn't be enough. Ha. I remember thinking at that time I hoped they would need to build another facility in a geographically diverse location both for capacity and business continuity. Sounds like MNKD and UTHR are moving that way as well. For sure Mike spent some time talking about adding capacity for Tyvaso DPI, especially if the additional indications are approved. I got the feeling they are having to manage through the demand. A good problem to have although adding capacity is not a trivial exercise or a quick one. |
|
|
|
Post by kc on Apr 17, 2023 15:18:55 GMT -5
All these posts urging awesomo to sell were so persuasive, I was about to pull the trigger but gorman you talked me off the ledge. Not epic (so we can’t accuse you of exaggerating) but “almost miraculous” that we are here, plus “pretty remarkable” Afrezza script growth at 800 TRx in year nine. I guess if we can keep saying “30% year over year” that is comforting. All this and we can still buy shares under $0.80 RS adjusted. Heck no I’m not selling! |
|
